Jun 22, 2024, 14:35
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
FDA Oncology shared on X:
“FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer.”
Source: FDA Oncology/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 09:31
Nov 14, 2024, 09:26
Nov 14, 2024, 09:21
Nov 14, 2024, 09:15
Nov 14, 2024, 00:19